Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 11,158 shares at $113.92 ($1.3M) on 2018-11-12, disclosed to the SEC on 2018-11-13.
Open-market sale of $1.3M BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.10 | 2,958 | $329K | 26.2% |
| 2 | $112.18 | 4,000 | $449K | 35.8% |
| 3 | $113.03 | 2,527 | $286K | 22.8% |
| 4 | $113.92 | 1,173 | $134K | 10.6% |
| 5 | $116.56 | 500 | $58K | 4.6% |
| Total | $112.47 avg | 11,158 |
| $1.3M |
| 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-12-19 | $1.4M | — | Filing → |